Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity
Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 11,831 shares of STOK, which is worth approximately $409,944. The most recent transaction as insider was on Oct 03, 2025, when has been sold 10,000 shares (Common Stock) at a price of $25.07 per share, resulting in proceeds of $250,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11.8K
62.52%
3M change
355.39%
12M change
Total Value Held
$409,944
Jonathan Allan Transaction History
JA
Jonathan Allan
GENERAL COUNSEL & CORP SEC
Bedford, MA